Gaetano A Lanza Selected Research

Gaetano A Lanza Research Topics

Disease

8	Microvascular Angina (Cardiac Syndrome X) 02/2018 - 05/2005
5	Coronary Artery Disease (Coronary Atherosclerosis) 04/2019 - 05/2007
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 10/2002
4	Myocardial Infarction 04/2019 - 08/2005
4	Pathologic Constriction (Stenosis) 01/2018 - 05/2007
4	Ischemia 01/2014 - 05/2005
4	ST Elevation Myocardial Infarction 01/2014 - 09/2010
4	Unstable Angina 02/2009 - 11/2002
3	Type 2 Diabetes Mellitus (MODY) 01/2017 - 12/2010
3	Inflammation (Inflammations) 12/2010 - 10/2002
2	Dyspnea (Shortness of Breath) 10/2022 - 01/2018
2	Acute Coronary Syndrome 04/2019 - 01/2015
2	Heart Failure 01/2015 - 04/2014
2	Coronary Vasospasm (Coronary Artery Vasospasm) 01/2014 - 11/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2013 - 12/2010
2	Chest Pain (Chest Pains) 04/2010 - 05/2005
1	Non-ST Elevated Myocardial Infarction 04/2019
1	Coronary Stenosis (Coronary Artery Stenosis) 09/2016
1	Hypotension (Low Blood Pressure) 01/2015
1	Aspiration Pneumonia 01/2015
1	Nemaline Myopathies (Nemaline Myopathy) 01/2015
1	Pain (Aches) 02/2014
1	Atrial Fibrillation 01/2014
1	Bundle-Branch Block (Fascicular Block) 11/2013
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2013
1	Diabetes Mellitus 01/2013
1	Ventricular Fibrillation 01/2012
1	Ventricular Tachycardia 01/2012
1	Epilepsy (Aura) 04/2011
1	Brain Diseases (Brain Disorder) 04/2011
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 04/2011
1	Epileptic Syndromes 04/2011
1	Angina Pectoris 01/2011
1	Human Influenza (Influenza) 01/2011
1	Stable Angina 02/2009
1	Atherosclerotic Plaque (Atheroma) 02/2009
1	No-Reflow Phenomenon 05/2007
1	Drug Resistant Epilepsy 01/2007
1	Muscular Dystrophies (Muscular Dystrophy) 08/2006
1	Myotonic Dystrophy (Dystrophia Myotonica) 08/2006
1	Infarction (Infarctions) 06/2005
1	Infections 10/2002

Drug/Important Bio-Agent (IBA)

4	Adrenergic Agents (Adrenergic Drugs)IBA 04/2011 - 11/2008
4	C-Reactive ProteinIBA 01/2011 - 11/2002
3	Adenosine (Adenocard)FDA LinkGeneric 10/2022 - 06/2012
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2022 - 09/2016
2	Vasodilator Agents (Vasodilators)IBA 09/2016 - 01/2014
2	IvabradineIBA 01/2015 - 04/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2011 - 01/2007
2	AntibodiesIBA 02/2009 - 10/2002
2	AntigensIBA 02/2009 - 06/2005
2	oxidized low density lipoproteinIBA 05/2007 - 10/2002
1	pro-brain natriuretic peptide (1-76)IBA 10/2022
1	Natriuretic PeptidesIBA 10/2022
1	TroponinIBA 04/2019
1	Carvedilol (Coreg)FDA LinkGeneric 01/2015
1	isosorbide-5-mononitrate (Ismo)FDA LinkGeneric 01/2015
1	Imipramine (Janimine)FDA LinkGeneric 02/2014
1	salicylhydroxamic acid (SHAM)IBA 01/2014
1	Fibrinogen (Factor I)FDA Link 01/2014
1	NitratesIBA 06/2013
1	Isosorbide Dinitrate (Isordil)FDA LinkGeneric 06/2013
1	Ranolazine FDA Link 01/2013
1	Insulin (Novolin)FDA Link 01/2013
1	Sodium Channels (Sodium Channel)IBA 04/2011
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2011
1	VaccinesIBA 01/2011
1	Pioglitazone (Actos)FDA Link 12/2010
1	3-Iodobenzylguanidine (Iobenguane)IBA 03/2010
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2010
1	Proteins (Proteins, Gene)FDA Link 02/2009
1	Monoclonal AntibodiesIBA 02/2009
1	Oxygen (Dioxygen)IBA 01/2009
1	Dobutamine FDA LinkGeneric 01/2008
1	Ethanol (Ethyl Alcohol)IBA 01/2008
1	LDL Lipoproteins (beta Lipoproteins)IBA 05/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007
1	MD1IBA 08/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2002

Therapy/Procedure

8	Percutaneous Coronary Intervention 01/2016 - 08/2005
6	Therapeutics 01/2021 - 12/2010
4	Spinal Cord Stimulation 02/2014 - 05/2005
2	Stents 01/2018 - 09/2016
1	Glycemic Control 01/2017
1	Tracheostomy 01/2015
1	Cardiac Rehabilitation 01/2015
1	Complementary Therapies (Alternative Medicine) 02/2014
1	Radiofrequency Ablation 01/2014
1	Catheter Ablation 01/2014
1	Cardiac Resynchronization Therapy 11/2013
1	Sympathectomy (Sympathectomies) 11/2012
1	Patient Readmission 04/2010
1	Vagus Nerve Stimulation 01/2007
1	Drug Therapy (Chemotherapy) 05/2005
1	Length of Stay 11/2002